Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator

被引:8
|
作者
Kolk, Maarten Z. H. [1 ,10 ]
Ruiperez-Campillo, Samuel [2 ,3 ,8 ,9 ]
Alvarez-Florez, Laura [4 ]
Deb, Brototo [2 ,3 ]
Bekkers, Erik J. [5 ]
Allaart, Cornelis P. [6 ]
Lingen, Anne-Lotte C. J. Van Der [6 ]
Clopton, Paul [2 ,3 ]
Isgum, Ivana [4 ,5 ,7 ]
Wilde, Arthur A. M. [10 ]
Knops, Reinoud E. [1 ,10 ]
Narayan, Sanjiv M. [2 ,3 ]
Tjong, Fleur V. Y. [1 ,2 ,3 ,10 ,11 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Clin & Expt Cardiol, Heart Ctr, Meibergdreef 9, Amsterdam, Netherlands
[2] Stanford Univ, Dept Med, Stanford, CA USA
[3] Stanford Univ, Cardiovasc Inst, Stanford, CA USA
[4] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, Amsterdam, Netherlands
[5] Univ Amsterdam, Fac Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands
[6] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam UMC, De Boelelaan 1118, NL-1118 Amsterdam, Netherlands
[7] Univ Amsterdam, Amsterdam UMC, Dept Radiol & Nucl Med, Meibergdreef 9, Amsterdam, Netherlands
[8] Swiss Fed Inst Technol Zurich ETHz, Dept Informat Technol & Elect Engn, Gloriastr 35, Zurich, Switzerland
[9] Univ Politecn Valencia, ITACA Inst, Camino Vera S-N, Valencia, Spain
[10] Amsterdam Cardiovasc Sci, Heart Failure & Arrhythmias, Amsterdam, Netherlands
[11] Univ Amsterdam, Heart Ctr, NL-1105 AZ Amsterdam, Netherlands
来源
EBIOMEDICINE | 2024年 / 99卷
基金
荷兰研究理事会;
关键词
Cardiology; Machine learning; Deep learning; Electrocardiography; Sudden cardiac death; SUDDEN CARDIAC DEATH; SURVIVAL; RISK; CHALLENGES; ALTERNANS;
D O I
10.1016/j.ebiom.2023.104937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Risk stratification for ventricular arrhythmias currently relies on static measurements that fail to adequately capture dynamic interactions between arrhythmic substrate and triggers over time. We trained and internally validated a dynamic machine learning (ML) model and neural network that extracted features from longitudinally collected electrocardiograms (ECG), and used these to predict the risk of malignant ventricular arrhythmias. Methods A multicentre study in patients implanted with an implantable cardioverter-defibrillator (ICD) between 2007 and 2021 in two academic hospitals was performed. Variational autoencoders (VAEs), which combine neural networks with variational inference principles, and can learn patterns and structure in data without explicit labelling, were trained to encode the mean ECG waveforms from the limb leads into 16 variables. Supervised dynamic ML models using these latent ECG representations and clinical baseline information were trained to predict malignant ventricular arrhythmias treated by the ICD. Model performance was evaluated on a hold-out set, using time-dependent receiver operating characteristic (ROC) and calibration curves. Findings 2942 patients (61.7 +/- 13.9 years, 25.5% female) were included, with a total of 32,129 ECG recordings during a mean follow-up of 43.9 +/- 35.9 months. The mean time-varying area under the ROC curve for the dynamic model was 0.738 +/- 0.07, compared to 0.639 +/- 0.03 for a static (i.e. baseline-only model). Feature analyses indicated dynamic changes in latent ECG representations, particularly those affecting the T-wave morphology, were of highest importance for model predictions. Interpretation Dynamic ML models and neural networks effectively leverage routinely collected longitudinal ECG recordings for personalised and updated predictions of malignant ventricular arrhythmias, outperforming static models. Funding This publication is part of the project DEEP RISK ICD (with project number 452019308) of the research programme Rubicon which is (partly) financed by the Dutch Research Council (NWO). This research is partly funded by the Amsterdam Cardiovascular Sciences (personal grant F.V.Y.T). Copyright (c) 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [1] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFICACY, COMPLICATIONS AND SURVIVAL IN PATIENTS WITH MALIGNANT VENTRICULAR ARRHYTHMIAS
    KELLY, PA
    CANNOM, DS
    GARAN, H
    MIRABAL, GS
    HARTHORNE, JW
    HURVITZ, RJ
    VLAHAKES, GJ
    JACOBS, ML
    ILVENTO, JP
    BUCKLEY, MJ
    RUSKIN, JN
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) : 1278 - 1286
  • [2] Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias
    Albert, Christine M.
    Rosenthal, Lawrence
    Calkins, Hugh
    Steinberg, Jonathan S.
    Ruskin, Jeremy N.
    Wang, Paul
    Muller, James E.
    Mittleman, Murray A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (23) : 2233 - 2240
  • [3] C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator
    Biasucci, L. M.
    Giubilato, G.
    Biondi-Zoccai, G.
    Sanna, T.
    Liuzzo, G.
    Piro, M.
    De Martino, G.
    Ierardi, C.
    dello Russo, A.
    Pelargonio, G.
    Bellocci, F.
    Crea, F.
    HEART, 2006, 92 (08) : 1147 - 1148
  • [4] SHOCK WITHOUT WIRES: A LOOK AT SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR COMPARED TO TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR VENTRICULAR ARRHYTHMIAS
    Guice, K. C.
    Raja, J.
    Oberoi, M.
    Khouzam, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 493 - 493
  • [5] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
    Raja, Joel
    Guice, Kenneth
    Oberoi, Mansi
    Whitwell, Samantha
    Asbeutah, Abdul Aziz
    Russell, Alex
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [6] False negative detections of ventricular arrhythmias in implantable cardioverter-defibrillator
    Królak, T
    Lubiñski, A
    Kempa, M
    Pazdyga, A
    Lewicka-Nowak, E
    Zienciuk, A
    Swiatecka, G
    EUROPEAN HEART JOURNAL, 2003, 24 : 276 - 276
  • [7] TREATMENT OF MALIGNANT VENTRICULAR ARRHYTHMIAS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    SLATER, AD
    SINGER, I
    STAVENS, CS
    ZEECHENG, C
    GANZEL, BL
    KUPERSMITH, J
    MAVROUDIS, C
    GRAY, LA
    ANNALS OF SURGERY, 1989, 209 (05) : 635 - 641
  • [8] Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment
    Barron, HV
    Khan, HH
    Viskin, S
    Heller, K
    Kalman, JM
    Scheinman, MM
    Lesh, MD
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (09): : 1180 - 1184
  • [9] Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter-Defibrillator
    Efimova, Elena
    Zeynalova, Samira
    Eifert, Sandra
    Dashkevich, Alexey
    Borger, Michael Andrew
    Meyer, Anna L.
    Garbade, Jens
    Darma, Angeliki
    Bode, Kerstin
    Arya, Arash
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025, 36 (02) : 387 - 395
  • [10] Does right ventricular pacing increase the risk of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator?
    Josiak, Krystian
    Nowak, Krzysztof
    Fuglewicz, Artur
    Jagielski, Dariusz
    Banasiak, Waldemar
    Ponikowski, Piotr
    KARDIOLOGIA POLSKA, 2014, 72 (04) : 381 - 384